Vimarsana
Biggest News Aggregation in the World

Advancing Translational News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advancing Translational. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advancing Translational Today - Breaking & Trending Today

U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE - Vimarsana News

U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA)...

DanceBlue Clinic tests intervention to reduce financial burden on patients and caregivers - Vimarsana News

DanceBlue Clinic tests intervention to reduce financial burden on patients and caregivers

Researchers at the University of Kentucky College of Nursing and DanceBlue Kentucky Children’s Hospital Hematology/Oncology Clinic found that receiving financial and legal navigation services improves levels of financial toxicity and quality of life for patients and caregivers.

Source: uky.edu
Lahey, UMass Chan partner on new research hub - Vimarsana News

Lahey, UMass Chan partner on new research hub

UMass Chan Medical School and Lahey Hospital & Medical Center, part of the Beth Israel Lahey Health system, have signed a research affiliation agreement to create a new quantitative science research hub to improve health outcomes and disparities through population health, digital medicine and health systems science.

COVID-19 rapid tests still work against new variants – researchers keep 'testing the tests,' and they pass - Vimarsana News

COVID-19 rapid tests still work against new variants – researchers keep 'testing the tests,' and they pass

Research shows that rapid antigen tests are performing as well at detecting the most recent dominant variants as they did with the earliest strains in the COVID-19 pandemic.

Source: gavi.org
Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial compares the effect of donor human milk on neurodevelopmental outcomes at 22 to 26 months’ corrected age compared with preterm in